Veradigm to Participate in Barclays 26th Annual Global Healthcare Conference
Veradigm Inc. (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions announced today that Dr. Yin Ho, Veradigm interim Chief Executive Officer and board member, Lee Westerfield, interim Chief Financial Officer, and Will Manidis, Senior Vice President and the former CEO of ScienceIO, will participate in a fireside chat and investor Q&A, as well as meet with investor attendees during the Barclays 26th Annual Global Healthcare Conference on Wednesday, March 13th, 2024 at 2:05 PM EDT.
The webcast will be available in the investor section of the company's website at investor.veradigm.com, with an archived version accessible later that same day.
About Veradigm®
Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. For more information about how Veradigm is fulfilling its mission of Transforming Health, Insightfully, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, and YouTube.
Today, a decision was issued by the Court of Appeals Division I in the State of Washington in Erickson v. Monsanto, ruling in Monsanto's favor on multiple grounds.
This decision reverses the initial verdict of $185 million in its entirety and...
BTQ Technologies Corp. (the "Company") (CBOE CA: BTQ) is providing this bi-weekly update on the status of the management cease trade order issued on April 3, 2024 (the "MCTO"), by its principal regulator, the British Columbia Securities Commission...
Pangea Entertainment Productions (Venice, Ca.) and Big Bang Mediaverse (Mumbai, India) announce a partnership to create and produce innovative multiplatform content aimed at younger and connected audiences globally and in India. The first program in...
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Poseida Therapeutics, Inc. today announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas, "Xyphos") and Poseida have entered into a...
RiskOpsAItm, the Award Winning Pioneer in AI Driven Integrated Risk Modeling & Decision Supremacy, hosts Ethical Dimensions of AI: A Deep Dive into Data Privacy and Security.
"We are delighted...
Landlord Studio, the leading property management accounting software for self-managing landlords announced its new free listing syndication feature in partnership with Zillow and Zumper.
Charles Chan, CEO of Landlord Studio said, "We're delighted to...
